Literature DB >> 27450578

Chronic methamphetamine self-administration disrupts cortical control of cognition.

Aurelien Bernheim1, Ronald E See2, Carmela M Reichel3.   

Abstract

Methamphetamine (meth) is one of the most abused substances worldwide. Chronic use has been associated with repeated relapse episodes that may be exacerbated by cognitive impairments during drug abstinence. Growing evidence demonstrates that meth compromises prefrontal cortex activity, resulting in persisting attentional and memory impairments. After summarizing recent studies of meth-induced cognitive dysfunction using a translationally relevant model of self-administered meth, this review emphasizes the cortical brain changes contributing to cognitive dysregulation during abstinence. Finally, we propose the use of cognitive enhancers during abstinence that may promote a drug-free state by reversing cortical dysfunction linked with prolonged meth abuse.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Attention; Cognitive deficits; Glutamate; Methamphetamine; Object recognition; Perirhinal; Prefrontal

Mesh:

Substances:

Year:  2016        PMID: 27450578      PMCID: PMC5030184          DOI: 10.1016/j.neubiorev.2016.07.020

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  198 in total

1.  The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.

Authors:  M Carli; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

2.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.

Authors:  Carmela M Reichel; Meghin G Gilstrap; Lauren A Ramsey; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

3.  Cortical afferents of the perirhinal, postrhinal, and entorhinal cortices of the rat.

Authors:  R D Burwell; D G Amaral
Journal:  J Comp Neurol       Date:  1998-08-24       Impact factor: 3.215

4.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

5.  The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat.

Authors:  A Ennaceur; J P Aggleton
Journal:  Behav Brain Res       Date:  1997-11       Impact factor: 3.332

6.  Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Authors:  Paul J Fletcher; Catherine C Tenn; Zoë Rizos; Vedran Lovic; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

7.  Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing.

Authors:  R Dias; T W Robbins; A C Roberts
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

Review 8.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

9.  Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

Authors:  Tracie A Paine; Hilarie C Tomasiewicz; Kehong Zhang; William A Carlezon
Journal:  Biol Psychiatry       Date:  2007-03-07       Impact factor: 13.382

10.  Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats.

Authors:  Marek Schwendt; Carmela M Reichel; Ronald E See
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

View more
  19 in total

1.  A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.

Authors:  Qiu T Ruan; Neema Yazdani; Benjamin C Blum; Jacob A Beierle; Weiwei Lin; Michal A Coelho; Elissa K Fultz; Aidan F Healy; John R Shahin; Amarpreet K Kandola; Kimberly P Luttik; Karen Zheng; Nathaniel J Smith; Justin Cheung; Farzad Mortazavi; Daniel J Apicco; Durairaj Ragu Varman; Sammanda Ramamoorthy; Peter E A Ash; Douglas L Rosene; Andrew Emili; Benjamin Wolozin; Karen K Szumlinski; Camron D Bryant
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

2.  Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.

Authors:  Seyedeh Masoumeh Seyedhosseini Tamijani; Elmira Beirami; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Cogn Process       Date:  2017-09-25

3.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

4.  Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.

Authors:  Linhong Jiang; Ruiming Zhu; Qian Bu; Yan Li; Xue Shao; Hui Gu; Jueying Kong; Li Luo; Hailei Long; Wei Guo; Jingwei Tian; Yinglan Zhao; Xiaobo Cen
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

5.  Chemogenetic inhibition of corticostriatal circuits reduces cued reinstatement of methamphetamine seeking.

Authors:  Angela M Kearns; Benjamin M Siemsen; Jordan L Hopkins; Rachel A Weber; Michael D Scofield; Jamie Peters; Carmela M Reichel
Journal:  Addict Biol       Date:  2021-08-25       Impact factor: 4.280

6.  Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex.

Authors:  Monserrat Armenta-Resendiz; Ahlem Assali; Evgeny Tsvetkov; Christopher W Cowan; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2022-07-04       Impact factor: 8.294

7.  Effects of resilience on impulsivity, cognition and depression during protracted withdrawal among Chinese male methamphetamine users.

Authors:  He He; Siyao Zhou; Chenhui Peng; Wang Ran; Siyu Tong; Lan Hong; Fangfang Cai; Wei Jin; Yile Jiang; Mengjia Li; Xuanping Wang; Mengdan Luo; Wei Wang; Ke Zhao
Journal:  BMC Psychiatry       Date:  2022-06-21       Impact factor: 4.144

8.  Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex.

Authors:  Betina González; Subramaniam Jayanthi; Natalia Gomez; Oscar V Torres; Máximo H Sosa; Alejandra Bernardi; Francisco J Urbano; Edgar García-Rill; Jean-Lud Cadet; Verónica Bisagno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-12-13       Impact factor: 5.067

9.  Blockade of TRPV1 Inhibits Methamphetamine-induced Rewarding Effects.

Authors:  Yu-Hua Tian; Shi-Xun Ma; Kwang-Wook Lee; Sunmee Wee; George F Koob; Seok-Yong Lee; Choon-Gon Jang
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

10.  Effects of Mild Blast Traumatic Brain Injury on Cognitive- and Addiction-Related Behaviors.

Authors:  Matthew J Muelbl; Megan L Slaker; Alok S Shah; Natalie N Nawarawong; Clayton H Gerndt; Matthew D Budde; Brian D Stemper; Christopher M Olsen
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.